Glibenclamide attenuates osteoarthritis by suppressing NLRP3 inflammasome activation in synovial macrophages through the MAPK pathway
Open Access
- 26 February 2026
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Osteoarthritis (OA) is a chronic joint disorder characterized by progressive cartilage degeneration, synovial inflammation, and abnormal subchondral bone rKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20191492)
- Natural Science Foundation of Jiangsu Province (KY202207)
This publication has 48 references indexed in Scilit:
- Isoliensinine suppresses chondrocytes pyroptosis against osteoarthritis via the MAPK/NF-κB signaling pathwayInternational Immunopharmacology, 2024
- GDF11 protects against mitochondrial-dysfunction-dependent NLRP3 inflammasome activation to attenuate osteoarthritisJournal of Advanced Research, 2024
- Inflammatory Fibroblast‐Like Synoviocyte‐Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage GlycolysisAdvanced Science, 2024
- Genetic underpinning of the comorbidity between type 2 diabetes and osteoarthritisThe American Journal of Human Genetics, 2023
- Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K/Akt/NF-κB and NLRP3/caspase-1/GSDMD signalingBiomedicine & Pharmacotherapy, 2022
- The NLRP3 inflammasome: regulation by metabolic signalsTrends in Immunology, 2022
- Macrophages regulate the progression of osteoarthritisOsteoarthritis and Cartilage, 2020
- The role of macrophages in osteoarthritis and cartilage repairOsteoarthritis and Cartilage, 2020
- The Antidiabetic Agent Glibenclamide Protects Airway Hyperresponsiveness and Inflammation in MiceInflammation, 2014
- Osteoarthritis and cartilage: The role of cytokinesCurrent Rheumatology Reports, 2000